European Digital PCR and qPCR Market

Europe Digital PCR and qPCR Market Size (2024 to 2029)

The digital PCR and real-time PCR (qPCR) market in Europe was valued at USD 969.2 million in 2023 and is expected to grow at a CAGR of 8.9% from 2024 to 2029. The European market is anticipated to be worth USD 1616.5 million by 2029 from USD 1055.4 million in 2024.

The growing use of real-time PCR and digital PCR for identifying genetic disorders and other infectious diseases like tuberculosis, malaria, and others is a significant factor driving the digital PCR and qPCR market in Europe. Furthermore, the further expansion of the European market is boosted by the increased focus of government and business entities on developing unique and creative digital PCR and qPCR products. Furthermore, the emergence of innovative and improved genomic analysis tools across the region is another significant factor promoting the digital PCR and qPCR market expansion in Europe. In addition, the high efficiency of digital PCR and qPCR equipment for estimating disease-causing microorganisms and diagnostics analysis is fueling the growth of the digital PCR and qPCR market in Europe.

Increasing healthcare spending in emerging economies and other developed and developing countries around the world, as a result of an increase in the incidence of genetic disorders and other chronic diseases like cancer, as well as technological advancements, is expected to create lucrative opportunities for market players in the region over the forecast period. The advantages of digital PCR over traditional PCR, such as accuracy, sensitivity, and flexibility, are expected to drive the European digital PCR and qPCR market forward throughout the forecast period. Furthermore, increasing uses of qPCR consumables and reagents and other clinical applications are expected to provide additional growth prospects for this market.

The growth of the digital PCR and qPCR market in the European region is forecasted to be hampered by the technical problems, the high initial cost of dPCR and qPCR, the necessity for large-scale capital investments to create advanced equipment. In addition, the adoption rate of digital PCR and qPCR in Europe is also constrained by technical difficulties connected to PCR, another key factor impeding the market's growth.

This research report on the Europe digital PCR and the qPCR market has been segmented & sub-segmented into the following categories:

Europe Digital PCR and qPCR Market - By Product:

• Consumables
• Reagents and Instruments

Europe Digital PCR and qPCR Market - By Technology:

• Quantitative PCR
• Digital PCR

Europe Digital PCR and qPCR Market - By Application:

• Tumors
• Blood Testing
• Pathogen Detection
• Research & Forensics

Europe Digital PCR and qPCR Market - By End User:

• Hospitals
• Research & Forensic Centers
• Pharmaceutical & Bio-Technological Firms
• Academic Institutions

Europe Digital PCR and qPCR Market - By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Over the forecast period, Europe is predicted to be the second-largest region for dPCR and qPCR across the globe. The wide range of applications of qPCR and dPCR technologies in human genetic testing and forensic sciences are some of the factors driving the region's market growth. Because of the rising frequency of infectious and chronic diseases, as well as increased R&D initiatives to develop breakthrough genomic techniques such as qPCR and dPCR, emerging markets are likely to offer considerable growth potential. The expansion of healthcare infrastructure increased healthcare expenditure, and lower procedural costs for qPCR and dPCR-based illness diagnostics are all driving these markets forward. The development of healthcare infrastructure in emerging countries is accompanied by rapid upgrading of healthcare facilities. As a result, clinical diagnostic procedures are in greater demand among diagnostic laboratories, resulting in more sales of clinical qPCR and dPCR products.

The UK is expected to dominate the European market for Digital PCR and Quantitative PCR during the forecast period. There is strong growth in the market due to key factors such as the presence of key players, high incidence of chronic diseases in the region, and established healthcare infrastructure.

KEY MARKET PLAYERS:

Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company are a few of the noteworthy companies operating in the European Digital PCR and qPCR Market.